Talking therapy via video aims to boost self-care in lung disease patients
NCT ID NCT07179562
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether motivational interviewing, delivered through video calls and online platforms, can improve self-care in 124 adults with idiopathic pulmonary fibrosis (IPF). Participants will be randomly assigned to receive the counseling or usual care. Researchers will measure changes in self-care behaviors, anxiety, quality of life, and hospital visits. The goal is to see if remote support can help patients manage their condition better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
motivational interviewing (a counseling approach delivered remotely via video calls and digital platforms)
What this could lead to
If it works, this could show that remote counseling helps people with IPF better manage their daily care and reduce hospital visits.
What could go wrong
This is a small, early-stage study focused on behavior change, not a drug or cure. The results may not apply to all IPF patients, and the benefit may be modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS (IPF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.